Symptomatic secondary hyponatraemia due to combined treatment anticonvulsant and antidepressant: Risk of sudden death in epilepsy?;Hiponatremia sintomática secundaria a tratamiento conjunto anticomicial y antidepresivo: ¿riesgo de muerte súbita en epilepsia?

Anales de Medicina Interna

Volumn 24, Issue 7, 2007, Pages 335-338

  Ruiz Ginés, Miguel Ángel ^a,d   Garcia Garcia S ^a   Ruiz Gines J A ^b   Tze Kiong, E ^c   Fernandez Rodriguez E ^a  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NONE   (Spain)

Author keywords

Carbamazepine; Epilepsy; Hyponatraemia; Lamotrigine; Neuroprotections; Selenium; Sudden death; Syncope; Venlafaxine

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; EPILEPSY; FEMALE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; SUDDEN DEATH; SYNCOPE;

ADULT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; CARBAMAZEPINE; CYCLOHEXANOLS; DEATH, SUDDEN; DRUG INTERACTIONS; EPILEPSY; FEMALE; HUMANS; HYPONATREMIA; RISK FACTORS; TRIAZINES;

EID: 38549182373     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Nashef L. Sudden unexpected death in epilepsy: Terminology and definition. Epilepsia 1997; 38 (Supl. 11): S6-S8.
2. Oppenheimer S. Cardiac dysfunction during seizures and the sudden epileptic death syndrome. J R Soc Med 1990; 83: 134-6.
3. Hauser WA, et al. Mortality in patients with epilepsy. Epilepsia 1980; 21: 399-412.
4. Jones MW. Consequences of epilepsy: Why do we treat seizures? Canadian J Neurological Science 1998; 25 (Supl. 4): 24-6.
5. Timmings PL. Sudden unexpected death in epilepsy: is carbamazepine implicated? Seisure 1998; 7: 289-91.
6. Gordon N. The long Q-T syndromes. Brain and Development 1994; 16: 153-5.
7. Tavernor SJ, Brown SW, Tavernor RME, Gifford C. Electrocardiograph QT lengthening associated with epileptiform EEG discharges- A role in sudden unexplained death in epilepsy? Seizure 1996; 1: 79-83.
8. Langan Y, Nashef L, Sudden unexpected death in epilepsy (SUDEP) ACNR January/February 2003; 2: 6-8.
9. Alegre S, Araujo J, Rubio JM. Interacción claritromicina- carbamacepina: síntomas neurológicos e hiponatremia. An Med Intern 1998; 15: 48-9.
10. Arriba de G, machín JM, Balanza J. Síndrome de secreción inadecuada de ADH durante la administración de paroxetina. Med Clin (Barc) 2003; 121: 158-9.
11. Milne DB. Trace elements. In: Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry, 2 ed. Philadelphia; WB Saunders; 1994.
12. a ed. Elsevier; 2003. p. 437-99.
13. Matthew RP, Naif ZA Jr. Toxicology and therapeutic drug monitoring. In: McPherson RA , Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 21th ed. Saunders; 2007. p. 311-3.
14. Madhusoodanan S, Bougnovic OJ, Moise D, Brenner R, Markovitz S, Sotelo J. Hyponatremia associated with psycotropic medications. A review of the literature and spontaneous reports. Adverse Drug React Toxicol Rev 2002; 21: 17-29.
15. Stone S, Lange LS. Syncope and sudden unexpected death attributed to carbamacepine in a 20 year old epileptic. J Neurol Neurosurg Psychiatry 1987; 49: 1460-1.
16. th ed. London: Royal Pharmaceutical Society 1996; p. 369-72.
17. Committee on Safety of Medicines/Medicines Control Agency. Antidepressant-hyponatraemia induced. Current Problems 1994; 20: 5-6.
18. Klein EA. Selenium: Epidemiology and basic science. J Urol 2004; 171: S50-S3.
19. Gutiérrez-Álvarex AM, Moreno CB, González Reyes RE. Alteración de la concentración de selenio en la epilepsia. Rev Neurol 2005; 40: 111-6.
20. Remaekers VT, Calomme M, Vanden Berghe D, Makropoulos W. Selenium deficiency triggering intractable seizures. Neuropediatrics 1994; 25: 217-23.
21. Ficker M. Sudden unexplained death and injury in epilepsy. Epilepsia 2000; 41 (Supl. 2): S7-S12.